Insulin Glulisine, a fast-acting insulin administered subcutaneously used for treatment of adults, adolescents and children 6 years or older, with diabetes mellitus, where treatment with insulin is required.
Irbesartan is a potent, orally active, selective angiotensin-II receptor (type AT1) antagonist. It is expected to block all actions of angiotensin-II mediated by the AT1 receptor, regardless of the source or route of synthesis of angiotensin-II used to Effectively control Hypertension to normal Rates.
AUBAGIO® is a once-daily oral tablet that is indicated for adult patients with relapsing remitting multiple sclerosis (RRMS)
Enoxaparin Sodium is a low molecular weight heparin (LMWH) that is administered subcutaneously and used as antithrombotic agent.
Is a fully human monoclonal antibody with multiple indications in different therapeutic areas.
Insulin Glargine 100, a long-acting insulin administered subcutaneously and used to treat diabetes mellitus in adults, adolescents and children from the age of 2 years.
Lemtrada® is a monoclonal antibody produced in mammalian cells (Chinese Hamster Ovary).
Clopidogrel is an inhibitor of platelet aggregation administered orally and indicated for Secondary prevention of atherothrombotic events.
Alirocumab is a fully human IgG1 monoclonal antibody. It’s a PCSK9 inhibitor that is administered subcutaneously.
Isatuximab is an immunoglobulin G1 (IgG1) monoclonal antibody (mAb) for the treatment of adult patients with relapsed and refractory multiple myeloma in combined regimens.
Combination of Insulin Glargine (a basal insulin analog) & Lixisenatide (a GLP-1 receptor agonist) administered subcutaneously.
Levofloxacin is used in adults for the treatment of infections. The dosage depends on the type and severity of the infection and the susceptibility of the presumed causative pathogen.
Insulin Glargine 300, a long-acting insulin administered subcutaneously and used to treat diabetes mellitus in adults, adolescents and children from the age of 6 years.
Xenpozyme is FIRST AND ONLY APPROVED TREATMENT THAT ADDRESSES THE UNDERLYING CAUSE OF NON-CNS MANIFESTATIONS OF ASMD TYPE A/B OR TYPE B AND CAN HELP REVERSE DISEASE PROGRESSION IN PEDIATRIC AND ADULT PATIENTS.
Combination of Rosuvastatin Calcium & Ezetimibe used as adjunct to diet for treatment of Primary Hypercholesterolemia or Homozygous Familial Hypercholesterolemia.
▼ This drug is subject to additional monitoring, the reporting of suspected adverse reactions associated with this drug is a priority.